Surrey, UK, 26th May, 2010 - NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotechnology industries, is pleased to announce that Dr Hermann Osterwald has been reappointed to the board and as Treasurer of the International Association for Pharmaceutical Technology (APV) at a recent ceremony held during TechnoPharm 2010 (International Trade Fair for Life Science Process Technologies Pharma, Food and cosmetics) in Nürnberg, Germany.
Dr. Hermann Osterwald has been a member of APV since 1977 and was originally appointed to the APV board and as Treasurer in March 2006. Dr. Osterwald was appointed as Managing Director, Contract Manufacturing Services for NextPharma in September 2007 having previously held the role of Executive Vice President Operations since 2003. Previously he held various senior management positions in some of NextPharma’s German subsidiaries. Prior to this Dr. Osterwald gained considerable experience in a variety of senior roles within the Pharmaceutical industry dating back to 1981 including managing director for various subsidiaries of the GEHE group.
On this appointment Bill Wedlake, CEO, NextPharma Technologies commented “Dr. Hermann Osterwald is a highly valued colleague, his pharmaceutical knowledge and expertise has been of critical importance to the development of NextPharma. At NextPharma we believe that scientific innovation is central to long-term cost effective healthcare and fully support Dr Osterwald in his role at APV and as an avid supporter and promoter of all scientific development and innovation across the pharma and biotech industries”.
NextPharma develops, manufactures, packages, and distributes a broad range of products and formulations for its customers including solids, liquids and semi-solid dosage forms, antibiotics, hormones and controlled release medicines. It has an established leadership position in the high technology area of injectables manufacturing (lyophilized and liquid fill), with particular expertise in product development and manufacture of oncology medicines.
